Merck KGaA (ETR:MRK) Shares Down 1.4% – Should You Sell?

Shares of Merck KGaA (ETR:MRKGet Free Report) were down 1.4% during trading on Thursday . The stock traded as low as €142.25 ($145.15) and last traded at €143.00 ($145.92). Approximately 227,393 shares were traded during trading, The stock had previously closed at €145.00 ($147.96).

Merck KGaA Price Performance

The stock has a market capitalization of $18.42 billion, a PE ratio of 23.60, a P/E/G ratio of 2.37 and a beta of 0.71. The firm’s 50 day simple moving average is €142.94 and its 200 day simple moving average is €154.76. The company has a debt-to-equity ratio of 37.56, a current ratio of 1.31 and a quick ratio of 0.72.

Merck KGaA Company Profile

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Further Reading

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.